Clinical Trials
5
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:3
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (60.0%)Phase 2
2 (40.0%)Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Exploratory Efficacy of Nimacimab in Patients With Diabetic Gastroparesis
- First Posted Date
- 2019-04-03
- Last Posted Date
- 2020-01-18
- Lead Sponsor
- Bird Rock Bio, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT03900325
- Locations
- 🇺🇸
Panax Clinical Research, Miami, Florida, United States
🇺🇸International Research Associates, LLC, Miami, Florida, United States
🇺🇸PRN of Kansas, Wichita, Kansas, United States
Safety Tolerability, and PK of RYI-018 After Repeat Dosing in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)
Phase 1
Completed
- Conditions
- NAFLD
- First Posted Date
- 2017-08-25
- Last Posted Date
- 2019-03-14
- Lead Sponsor
- Bird Rock Bio, Inc.
- Target Recruit Count
- 84
- Registration Number
- NCT03261739
- Locations
- 🇨🇦
BRB Site, Toronto, Ontario, Canada
Study Evaluating Gerilimzumab´s Safety/Efficacy for Patients MTX or TNFα Antagonist Failed in Rheumatoid Arthritis
Phase 2
Withdrawn
- Conditions
- Rheumatoid Arthritis
- Interventions
- First Posted Date
- 2016-06-10
- Last Posted Date
- 2018-07-11
- Lead Sponsor
- Bird Rock Bio, Inc.
- Registration Number
- NCT02795299
News
No news found